Linkage of Laboratory Results to Medicare Fee-for-Service Claims

BACKGROUND: Medicare is the single largest purchaser of laboratory testing in the United States, yet test results associated with Medicare laboratory claims have historically not been available. OBJECTIVE: The purpose of this study was to describe both the linkage of laboratory results data to Medicare claims and the completeness of these results data. In a subgroup of beneficiaries initiating angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, we also demonstrate the generalizability of Medicare beneficiaries with laboratory values compared with those without laboratory values. We end with a discussion of the limitations and potential uses of these linked data. METHODS: We obtained information about laboratory orders and results for all Medicare fee-for-service beneficiaries in 10 eastern states who had outpatient laboratory tests conducted by a large national laboratory services vendor in 2011. Using a combination of direct identifiers and patient demographic characteristics, we linked patients in these laboratory data to Medicare beneficiaries, enabling us to associate test results with existing claims. RESULTS: Nearly all patients in the laboratory data were able to be linked to Medicare beneficiaries. There were over 2 million distinct beneficiaries with nearly 125 million specific test results in the laboratory data. For specific tests ordered in an outpatient or office setting in these 10 states, between 5% and 15% of them had linked laboratory data. Medicare beneficiaries initiating angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers who had laboratory results data had similar patient characteristics to those without results data. CONCLUSIONS: This novel linkage of laboratory results data to Medicare claims creates unprecedented opportunities for conducting comparative effectiveness research related to patient safety and quality

Angiotensin Receptor Blockers · Angiotensin-converting enzyme · Disclaimer · Family medicine · Fee-for-service · Generalizability theory · Health care · Medical prescription · Medicare Part D · Prescription drug · Test (biology) · Clinical Laboratory Practices and Quality Control · Health Promotion and Cardiovascular Prevention · Healthcare cost, quality, practices · Internal Medicine · Medicine · Nursing · Psychology

• Post-acute Ambulatory Care Service Use Among Patients Discharged Home After Stroke or TIA

  Anna M Kucharska-Newton, Jacquie R Halladay et al.•Medical Care•2023

  Incluir item

• Prescriber Continuity and Disease Control of Older Adults

  Matthew L Maciejewski, Bradley G Hammill et al.•Medical Care•2017

  Incluir item

• Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

  Peter C Austin•Communications in Statistics -…•2009

  Incluir item

• Measuring Performance Directly Using the Veterans Health Administration Electronic Medical Record

  Joseph L Goulet, Joseph Erdos et al.•Medical Care•2007

  Incluir item